Related Experiment Video
Updated: May 20, 2026

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
Published on: March 7, 2025
Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics
1Unité de Biologie Fonctionnelle et Adaptative, Sorbonne Paris Cité, Universite Paris Diderot, EAC4413 CNRS, 75205 Paris Cedex 13, France. creau@univ-paris-diderot.fr
Abstract:
Down syndrome is a complex disease that has challenged molecular and cellular research for more than 50 years. Understanding the molecular bases of morphological, cellular, and functional alterations resulting from the presence of an additional complete chromosome 21 would aid in targeting specific genes and pathways for rescuing some phenotypes. Recently, progress has been made by characterization of brain alterations in mouse models of Down syndrome. This review will highlight the main molecular and cellular findings recently described for these models, particularly with respect to their relationship to Down syndrome phenotypes.
Insights
Mouse models are advancing Down syndrome research by revealing molecular and cellular changes in the brain. This helps understand genetic alterations and potential therapeutic targets for Down syndrome phenotypes.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Down syndrome, caused by trisomy 21, presents complex challenges in molecular and cellular research.
- Understanding the molecular basis of Down syndrome phenotypes is crucial for developing targeted therapies.
Purpose of the Study:
- To review recent molecular and cellular findings in Down syndrome mouse models.
- To connect these findings to the characteristic phenotypes of Down syndrome.
Main Methods:
- Characterization of brain alterations in established mouse models of Down syndrome.
- Analysis of molecular and cellular data from these models.
Main Results:
- Recent studies in mouse models have elucidated key molecular and cellular brain alterations.
- These alterations provide insights into the pathogenesis of Down syndrome.
Conclusions:
- Down syndrome mouse models are valuable tools for dissecting the molecular underpinnings of the condition.
- Further research using these models can guide the development of strategies to ameliorate Down syndrome phenotypes.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Karyotyping
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Meiosis I
Meiosis vs. Mitosis
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
iPS Cell Differentiation
